Mobocertinib
id:
mobocertinib-288-462943
title:
Mobocertinib
text:
Mobocertinib, sold under the brand name Exkivity, is used for the treatment of non-small cell lung cancer. The most common side effects include diarrhea, rash, nausea, stomatitis, vomiting, decreased appetite, paronychia, fatigue, dry skin, and musculoskeletal pain. Mobocertinib is a small molecule tyrosine kinase inhibitor structurally similar to osimertinib. Its molecular target is epidermal growth factor receptor (EGFR) bearing mutations in the exon 20 region. Mobocertinib is an irreversible
brand slug:
wiki
category slug:
encyclopedia
description:
Small molecule tyrosine kinase inhibitor
original url:
https://en.wikipedia.org/wiki/Mobocertinib
date created:
date modified:
2024-03-21T00:30:27Z
main entity:
{"identifier":"Q105338009","url":"https://www.wikidata.org/entity/Q105338009"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/95/Mobocertinib.svg","width":512,"height":302}
fields total:
13
integrity:
15